6 December 2018 - The German market for innovative medicines is characterised by simultaneous underuse and overuse. ...
14 November 2018 - Germany’s health minister Jens Spahn has called for faster adoption of cheaper copies of biotech drugs ...
1 October 2018 - Effect on disease-free survival too small to conclude on overall survival. ...
12 Septemner 2018 - Novartis' breakthrough cancer drug Kymriah has been approved in Europe. Now comes the debate about its ...
2 July 2018 - Of the four dossier evaluations published by the IQWiG on 2 July, two have a striking similarity ...
21 June 2018 - The early benefit assessment of pharmaceuticals in Germany and their preceding market authorisation pursue different objectives. ...
13 June 2018 - In oncology clinical trials, cross-over is used frequently but may lead to uncertainties regarding treatment effects. ...
13 June 2018 - IQWiG employees criticise the publication practice of PALOMA-2 study authors. ...
13 June 2018 - The United Kingdom’s NICE publishes positive guidance for the first selective interleukin 23 inhibitor to treat moderate ...
6 June 2018 - Still no long-term studies and little direct comparisons of biologics/first-time also first-line therapy examined. ...
4 June 2018 - New chapters on HTA reports addressing topics proposed by the public and on the assessment of ...
26 April 2018 - Registration now possible/discussion about current method proposals of the EMA. ...
1 March 2018 - Significant benefits in terms of symptoms and especially in quality of life/dossier provides meaningful data. ...
19 February 2018 - Optional scientific advice for the early benefit assessment of pharmaceuticals is offered by the German decision maker, ...
18 January 2018 - Oncology remains by far the most common indication. ...